Cic edizioni internazionali
Functional Neurology

Management of spasticity with onabotulinumtoxinA: practical guidance based on the italian real-life post-stroke spasticity survey

Original Article, 37 - 43
doi: 10.11138/FNeur/2018.33.1.037
Tag this article
Abstract
Enhanced HTML Full text PDF
The present paper provides practical guidance on the management of adult spasticity with OnabotulinumtoxinA.
Advisory Board members reviewed the available evidence and discussed their personal experiences in order to address the unmet needs in the management of spasticity with botulinum toxin type A identified by the recent Italian Real-Life Post-Stroke Spasticity Survey.
Stroke patients should be referred to spasticity services that have adequate facilities and multidisciplinary teams with the necessary training, competence and expertise. The current literature shows a strong correlation between the development of
post-stroke spasticity and the degree of central sensorimotor system destruction/disorganization. Use of tools such as the Poststroke Checklist may help clinicians in the long-term follow-up of stroke patients.
The maximum dose of onabotulinumtoxinA — according to the current literature this ranges from 300U to 400U for upper limb and from 500U to 600U for lower limb aggregate postures — should be re-considered. In addition, there is a need for future consensus (also based on pharmacoeconomic considerations) on consistent clinical care models for the management of patients with post-stroke spasticity.

Vol. XXXIII (No. 4) 2018 October/December

  1. Music and neurorehabilitation: Yes, we can!
    Raglio A.
    doi: 10.11138/FNeur/2018.33.4.173
  2. Clinical and neuroimaging spectrum of hyperglycemia-associated chorea-ballism: systematic review and exploratory analysis of case reports
    Gómez-Ochoa S.A., Espín-Chico B.B., Pinilla-Monsalve G.D., Kaas B.M., Téllez-Mosquera L.E.
    doi: 10.11138/FNeur/2018.33.4.175
  3. Recovery of circadian melatonin rhythm after a melatonin holiday in daytime haemodialysis patients on long-term exogenous melatonin
    Sparla S., Koch B.C., Bosma R., Nagtegaal E.
    doi: 10.11138/FNeur/2018.33.4.188
  4. Multiple sclerosis and non-dystrophic myotonias: do they share a common pathophysiology?
    Portaro S., Naro A., Russo M., Bramanti P., Lauria P., D'Aleo G., La Rosa G., Bramanti A., Calabrò R.S.
    doi: 10.11138/FNeur/2018.33.4.194
  5. From paper to informatics: the Post Soft Care-App, an easy-to-use and fast tool to help therapists identify unmet needs in stroke patients
    De Bartolo D., Morone G., Lupo A., Aloise F., Baricich A., Di Francesco D., Calderone C., Cisari C., Verdecchia G., Sandrini G., Pistarini C., Antonucci G., Smania N., Paolucci S., Iosa M.
    doi: 10.11138/FNeur/2018.33.4.200
  6. Automated mechanical peripheral stimulation and postural control in subjects with Parkinson’s disease and freezing of gait: a randomized controlled trial
    Prusch J.S., Kleiner A.F.R., Salazar A.P., Pinto C., Marchese R.R., Galli M., Pagnussat A.S.
    doi: 10.11138/FNeur/2018.33.4.206
  7. Is bupropion useful in the treatment of post-stroke thalamic apathy? A case report and considerations
    Aragona B., De Luca R., Piccolo A., Le Cause M., Destro M., Casella C., Filoni S., Calabrò R.S.
    doi: 10.11138/FNeur/2018.33.4.213
  8. TIA patients with higher ABCD3-I scores are prone to a higher incidence of intracranial stenosis, unstable carotid plaques and multiple-vessel involvement
    Yu Q., Miao W., Han J.
    doi: 10.11138/FNeur/2018.33.4.217
  9. Is there a correlation between urological and cardiovascular dysfunction in Parkinson’s disease?
    Brusa L., Rocchi C., Ponzo V., Stanzione P., Finazzi E., Attanasio A.
    doi: 10.11138/FNeur/2018.33.4.225
  10. Cross-cultural adaptation and validation in the Italian population of the wolf motor function test in patients with stroke
    Berardi A., Dhrami L., Tofani M., Valente D., Sansoni J., Galeoto G.
    doi: 10.11138/FNeur/2018.33.4.229
  11. The dawn of algometry: Paolo Mantegazza’s research on pain
    Cani V.
    doi: 10.11138/FNeur/2018.33.4.254
Last Viewed articles: la lista degli ultimi x visitati.
  1. Management of spasticity with onabotulinumtoxinA: practical guidance based on the italian real-life post-stroke spasticity survey
    Sandrini G., Baricich A., Cisari C., Paolucci S., Smania N., Picelli A.
    doi: 10.11138/FNeur/2018.33.1.037
credits